Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmaceuticals business in India, for $11.75 billion. Organon is a global healthcare company formed from a Merck spinoff, with operations spanning multiple markets and supporting branded and specialty medicines. Sun Pharma acquires Organon to strengthen its global pharmaceuticals acquisition footprint and expand healthcare M&A capabilities across key therapeutic areas. The merger acquisition is structured as a strategic acquisition and is currently announced, with Sun Pharma acquisitions expected to accelerate international growth plans.